Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Top Cited Papers
Open Access
- 13 November 2024
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- p. 1-13
Abstract
Engineered virus-like particles (eVLPs) are promising vehicles for transient delivery of proteins and RNAs, including gene editing agents. We report a system for the laboratory evolution of eVLPs that enables the discovery of eVLP variants with improved properties. The system uses barcoded guide RNAs loaded within DNA-free eVLP-packaged cargos to uniquely label each eVLP variant in a library, enabling the identification of desired variants following selections for desired properties. We applied this system to mutate and select eVLP capsids with improved eVLP production properties or transduction efficiencies in human cells. By combining beneficial capsid mutations, we developed fifth-generation (v5) eVLPs, which exhibit a 2–4-fold increase in cultured mammalian cell delivery potency compared to previous-best v4 eVLPs. Analyses of v5 eVLPs suggest that these capsid mutations optimize packaging and delivery of desired ribonucleoprotein cargos rather than native viral genomes and substantially alter eVLP capsid structure. These findings suggest the potential of barcoded eVLP evolution to support the development of improved eVLPs.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (UG3AI150551, U01AI142756)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM118062)
- U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG009490)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL136135)
- U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY009339)
- Bill and Melinda Gates Foundation (Liu grant)
- Howard Hughes Medical Institute (Liu investigatorship)
This publication has 83 references indexed in Scilit:
- Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectorsGene Therapy, 2013
- Directed evolution of novel adeno-associated viruses for therapeutic gene deliveryGene Therapy, 2012
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Engineering of a Stable Retroviral Gene Delivery Vector by Directed EvolutionMolecular Therapy, 2008
- Directed evolution of adeno-associated virus yields enhanced gene delivery vectorsNature Biotechnology, 2006
- The Packaging Signal of MLV is an Integrated Module that Mediates Intracellular Transport of Genomic RNAsJournal of Molecular Biology, 2005
- Structural basis for packaging the dimeric genome of Moloney murine leukaemia virusNature, 2004
- Characterization of the Block in Replication of Nucleocapsid Protein Zinc Finger Mutants from Moloney Murine Leukemia VirusJournal of Virology, 1999
- Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: Implications for retroviral assembly mechanismsProceedings of the National Academy of Sciences, 1998
- The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivoJournal of Virology, 1996